(19)
(11)
EP 1 644 522 A2
(12)
(88)
Date of publication A3:
14.07.2005
(43)
Date of publication:
12.04.2006
Bulletin 2006/15
(21)
Application number:
04740533.7
(22)
Date of filing:
01.07.2004
(51)
International Patent Classification (IPC):
C12Q
1/68
(1980.01)
(86)
International application number:
PCT/EP2004/007167
(87)
International publication number:
WO 2005/005661
(
20.01.2005
Gazette 2005/03)
(84)
Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
(30)
Priority:
02.07.2003
US 484465 P
(71)
Applicants:
Novartis AG
4056 Basel (CH)
BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL
Novartis Pharma GmbH
1230 Wien (AT)
AT
(72)
Inventor:
LAVEDAN, Christian, Nicolas
Potomac, MD 20854 (US)
(74)
Representative:
von Sprecher, Georg et al
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)
(54)
GENES REGULATED IN OVARIAN CANCER AS PROGNOSTIC AND THERAPEUTIC TARGETS